Journal Watch · Frontiers in Immunology · 2026

Integrative analysis of FAERS, network toxicology, and Mendelian randomization identifies potential targets in paclitaxel-associated systemic sclerosis.

Overall, this study systematically explored potential molecular targets related to paclitaxel-associated SSc and provides hypothesis-generating insights that may guide future mechanistic studies and risk assessment strategies.

Wang X, Zhang CFrontiers in Immunology3 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1696820PMID: 42495626Study type: genomics / omics study

TL;DR

Overall, this study systematically explored potential molecular targets related to paclitaxel-associated SSc and provides hypothesis-generating insights that may guide future mechanistic studies and risk assessment strategies.

Key findings

  • Functional enrichment analyses revealed that these genes were involved in oxidative stress response, regulation of cell death, lipid metabolism, and apoptosis.
  • Among them, AKT1 and BCL2 were highlighted as central nodes in the protein-protein interaction network, representing candidate targets for further investigation.
  • Molecular docking simulations provided exploratory computational evidence of potential interactions, which do not confirm functional or mechanistic roles.
  • Overall, this study systematically explored potential molecular targets related to paclitaxel-associated SSc and provides hypothesis-generating insights that may guide future mechanistic studies and risk assessment strategies.

What they did

Mendelian randomization (MR) was then used to explore associations between these targets and SSc susceptibility. Disproportionality analyses demonstrated significant safety signals linking paclitaxel with SSc, scleroderma, and scleroderma-like reactions. A total of 76 overlapping targets were identified between paclitaxel and SSc. Based on expression quantitative trait loci (eQTL) from the IEU OpenGWAS database, MR analysis suggested 11 targets potentially associated with SSc susceptibility.

Full abstract (original)

Background: Systemic sclerosis (SSc) is a rare and complex autoimmune disease characterized by fibrosis of the skin and internal organs as well as vascular abnormalities. Studies have suggested that paclitaxel may induce adverse reactions resembling systemic sclerosis; however, the underlying mechanisms remain not fully understood. We retrieved reports of paclitaxel-associated SSc from the FDA Adverse Event Reporting System (FAERS). Potential shared targets between paclitaxel and SSc were identified through network toxicology analysis.

What they did: Mendelian randomization (MR) was then used to explore associations between these targets and SSc susceptibility. Disproportionality analyses demonstrated significant safety signals linking paclitaxel with SSc, scleroderma, and scleroderma-like reactions. A total of 76 overlapping targets were identified between paclitaxel and SSc. Based on expression quantitative trait loci (eQTL) from the IEU OpenGWAS database, MR analysis suggested 11 targets potentially associated with SSc susceptibility.

Results & conclusions: Functional enrichment analyses revealed that these genes were involved in oxidative stress response, regulation of cell death, lipid metabolism, and apoptosis. Among them, AKT1 and BCL2 were highlighted as central nodes in the protein-protein interaction network, representing candidate targets for further investigation. Molecular docking simulations provided exploratory computational evidence of potential interactions, which do not confirm functional or mechanistic roles. Overall, this study systematically explored potential molecular targets related to paclitaxel-associated SSc and provides hypothesis-generating insights that may guide future mechanistic studies and risk assessment strategies.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1696820 · PubMed 42495626.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

Overall, this study systematically explored potential molecular targets related to paclitaxel-associated SSc and provides hypothesis-generating insights that may guide future mechanistic studies and risk assessment strategies.

What type of study is this?

It is a genomics / omics study, published in Frontiers in Immunology in 2026. Mendelian randomization (MR) was then used to explore associations between these targets and SSc susceptibility.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1696820. PubMed ID: 42495626. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Wang X, Zhang C. Integrative analysis of FAERS, network toxicology, and Mendelian randomization identifies potential targets in paclitaxel-associated systemic sclerosis.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1696820.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/integrative-analysis-of-faers-network-toxicology-and-mendelian-randomiza-696820/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides